Roche's PiaSky has been approved by the European Commission, becoming the first therapy for rare blood disorder paroxysmal nocturnal haemoglobinuria (PNH) that can be given by monthly subcutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback